BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 17993956)

  • 1. Predicting the severity of systemic inflammatory response syndrome (SIRS)-associated coagulopathy with hemostatic molecular markers and vascular endothelial injury markers.
    Iba T; Gando S; Murata A; Kushimoto S; Saitoh D; Eguchi Y; Ohtomo Y; Okamoto K; Koseki K; Mayumi T; Ikeda T; Ishhikura H; Ueyama M; Ogura Y; Endo S; Shimazaki S;
    J Trauma; 2007 Nov; 63(5):1093-8. PubMed ID: 17993956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disseminated intravascular coagulation is a frequent complication of systemic inflammatory response syndrome.
    Gando S; Kameue T; Nanzaki S; Nakanishi Y
    Thromb Haemost; 1996 Feb; 75(2):224-8. PubMed ID: 8815564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of pre-disseminated intravascular coagulation stage with hemostatic molecular markers. The Mie DIC Study Group.
    Wada H; Wakita Y; Nakase T; Shimura M; Hiyoyama K; Nagaya S; Mori Y; Deguchi K; Shiku H
    Pol J Pharmacol; 1996; 48(2):225-8. PubMed ID: 9112656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations of haemostatic markers in various subtypes and phases of stroke.
    Yamazaki M; Uchiyama S; Maruyama S
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):707-12. PubMed ID: 7507362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical application of laboratory diagnosis: leukemia and DIC].
    Deguchi K; Zhao LJ; Shirakawa S
    Rinsho Byori; 1991 Jul; 39(7):736-42. PubMed ID: 1833571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of disseminated intravascular coagulation in relation to the score when treatment was begun. Mie DIC Study Group.
    Wada H; Wakita Y; Nakase T; Shimura M; Hiyoyama K; Nagaya S; Mori Y; Shiku H
    Thromb Haemost; 1995 Sep; 74(3):848-52. PubMed ID: 8571309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of hemostatic abnormality in various disease using molecular-I. Liver disease].
    Shimazu C; Fukuda T; Yugeta N; Yasuda K; Wakasugi K; Tahara C; Miyajima Y; Kazama M
    Rinsho Byori; 1991 Mar; 39(3):295-301. PubMed ID: 1828841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A clinical study on hemostatic fluctuation during and after cardiopulmonary bypass using hemostatic molecular markers].
    Nakajima H
    Nihon Kyobu Geka Gakkai Zasshi; 1992 Nov; 40(11):1987-97. PubMed ID: 1336789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study of hemostatic molecular marker].
    Wada H; Ioka M
    Rinsho Byori; 1997 Apr; 45(4):310-4. PubMed ID: 9136593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Responses to surgical stress in blood coagulation and fibrinolysis, platelet counts and thromboxane B2 after esophageal cancer operation].
    Shinohara M; Kurokawa H; Yoshihara Y; Kokubu S; Kusano T; Horie K; Murakami N; Nagai K; Nara N
    Rinsho Byori; 1997 Feb; 45(2):179-84. PubMed ID: 9121003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between clotting and collagen metabolism markers in rheumatoid arthritis.
    Gabazza EC; Osamu T; Yamakami T; Ibata H; Sato T; Sato Y; Shima T
    Thromb Haemost; 1994 Feb; 71(2):199-202. PubMed ID: 7514817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemostatic changes in systemic inflammatory response syndrome during continuous renal replacement therapy.
    García-Fernández N; Lavilla FJ; Rocha E; Purroy A
    J Nephrol; 2000; 13(4):282-9. PubMed ID: 10946808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative hypercoagulable state followed by hyperfibrinolysis related to wound healing after hepatic resection.
    Tsuji K; Eguchi Y; Kodama M
    J Am Coll Surg; 1996 Sep; 183(3):230-8. PubMed ID: 8784316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coagulation and fibrinolysis factors in dialysis patients with and without ischemic heart disease.
    Oda H; Ohno M; Ohashi H
    Adv Perit Dial; 2000; 16():152-5. PubMed ID: 11045282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum thrombomodulin as a prognostic marker of disseminated intravascular coagulation.
    Kotajima N; Kanda T; Fukumura Y; Kobayashi I
    J Med; 1999; 30(1-2):19-29. PubMed ID: 10515237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serial changes in hemostatic molecular markers after urokinase therapy of acute myocardial infarction].
    Goto S; Kawai Y; Watanabe K; Hori S; Abe S; Handa S; Ikeda Y
    Kokyu To Junkan; 1992 Jan; 40(1):89-95. PubMed ID: 1532665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated levels of markers of endothelial cell damage and markers of activated coagulation in patients with systemic necrotizing vasculitis.
    Hergesell O; Andrassy K; Nawroth P
    Thromb Haemost; 1996 Jun; 75(6):892-8. PubMed ID: 8822582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemostatic molecular markers before the onset of disseminated intravascular coagulation.
    Wada H; Sakuragawa N; Mori Y; Takagi M; Nakasaki T; Shimura M; Hiyoyama K; Nisikawa M; Gabazza EC; Deguchi K; Kazama M; Shiku H
    Am J Hematol; 1999 Apr; 60(4):273-8. PubMed ID: 10203100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Markers of systemic inflammation predicting organ failure in community-acquired septic shock.
    Takala A; Jousela I; Jansson SE; Olkkola KT; Takkunen O; Orpana A; Karonen SL; Repo H
    Clin Sci (Lond); 1999 Nov; 97(5):529-38. PubMed ID: 10545303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes of the hemostatic network in critically ill patients--is there a difference between sepsis, trauma, and neurosurgery patients?
    Boldt J; Papsdorf M; Rothe A; Kumle B; Piper S
    Crit Care Med; 2000 Feb; 28(2):445-50. PubMed ID: 10708181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.